Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126444602 | 12644460 | 2 | F | 20140714 | 20160822 | 20160811 | 20160823 | EXP | PHHO2014PL018418 | NOVARTIS | 75.23 | YR | F | Y | 65.00000 | KG | 20160823 | OT | PL | PL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126444602 | 12644460 | 1 | PS | OFATUMUMAB | OFATUMUMAB | 1 | Unknown | 1000 MG, | 125326 | 1000 | MG | ||||||||
| 126444602 | 12644460 | 2 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | 100 MG, QD | 500 | MG | 0 | 100 | MG | QD | |||||
| 126444602 | 12644460 | 3 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | 98 MG, UNK | 500 | MG | 0 | 98 | MG | ||||||
| 126444602 | 12644460 | 4 | SS | MESNA. | MESNA | 1 | Unknown | 332 G, UNK | 0 | 332 | G | ||||||||
| 126444602 | 12644460 | 5 | SS | MESNA. | MESNA | 1 | Unknown | 1324 MG, UNK | 0 | 1324 | MG | ||||||||
| 126444602 | 12644460 | 6 | SS | CALCIUM FOLINATE | LEUCOVORIN CALCIUM | 1 | Unknown | 15 MG, UNK | 0 | 15 | MG | ||||||||
| 126444602 | 12644460 | 7 | SS | GRANULOCYTE COLONY STIMULATING FACTOR | GRANULOCYTE COLONY-STIMULATING FACTOR NOS | 1 | Unknown | UNK | 0 | ||||||||||
| 126444602 | 12644460 | 8 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | Intravenous (not otherwise specified) | 1600 U, QD | 8000 | DF | 0 | 1600 | DF | QD | |||||
| 126444602 | 12644460 | 9 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | Intravenous (not otherwise specified) | 1630 MG, QD | 8000 | DF | 0 | 1630 | MG | QD | |||||
| 126444602 | 12644460 | 10 | SS | CYTARABINE. | CYTARABINE | 1 | Unknown | 830 U, BID | 3320 | DF | 0 | 830 | DF | BID | |||||
| 126444602 | 12644460 | 11 | SS | CYTARABINE. | CYTARABINE | 1 | Unknown | 815 MG, BID | 3320 | DF | 0 | 815 | MG | BID | |||||
| 126444602 | 12644460 | 12 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 12 MG, UNK | 0 | 12 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126444602 | 12644460 | 1 | Lymphoma |
| 126444602 | 12644460 | 2 | Lymphoma |
| 126444602 | 12644460 | 4 | Lymphoma |
| 126444602 | 12644460 | 6 | Lymphoma |
| 126444602 | 12644460 | 7 | Lymphoma |
| 126444602 | 12644460 | 8 | Lymphoma |
| 126444602 | 12644460 | 10 | Lymphoma |
| 126444602 | 12644460 | 12 | Lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126444602 | 12644460 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126444602 | 12644460 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126444602 | 12644460 | 1 | 20140704 | 0 | ||
| 126444602 | 12644460 | 2 | 20140704 | 20140708 | 0 | |
| 126444602 | 12644460 | 6 | 20140709 | 0 | ||
| 126444602 | 12644460 | 7 | 20140710 | 0 | ||
| 126444602 | 12644460 | 8 | 20140704 | 20140708 | 0 | |
| 126444602 | 12644460 | 10 | 20140704 | 20140705 | 0 | |
| 126444602 | 12644460 | 12 | 20140708 | 0 |